Every 10-Q that Willis Towers Watson Public Limited Company (WTW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow WTW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WTW filings page.
Willis Towers Watson Public Limited Company reported higher revenue for the three and six months ended June 30, 2026, with consolidated revenue rising from $2,261 million to $2,466 million for the quarter and from $4,484 million to $4,878 million year to date. Segment operating income increased to $564 million in the quarter and $1,162 million for the first half. However, net income attributable to WTW declined to $229 million for the quarter and $526 million for six months, with diluted EPS of $2.43 and $5.53, reflecting higher transaction and integration expenses of $61 million in the quarter and $102 million year to date, versus $2 million in the prior-year periods, and a higher effective tax rate.
Net cash from operating activities improved to $474 million for the first half of 2026, while significant investing outflows of $1,176 million were driven mainly by acquisitions, including the $1.05 billion Newfront Insurance Holdings Inc. transaction and the £150 million Cushon purchase, which added goodwill and customer-related intangibles. Cash and cash equivalents decreased to $1,627 million as total assets reached $30,559 million and long-term debt stood at $5,781 million. WTW returned capital through $750 million of share repurchases and dividends of $0.96 per share each quarter, reducing WTW shareholders’ equity to $7,688 million. The company also agreed to acquire the remaining 51% of Al-Futtaim Willis for $58 million in cash, expected to close in the second half of 2026 and move the current associate to full consolidation.
Willis Towers Watson posted solid first‑quarter growth with active deal activity. Revenue for the three months ended March 31, 2026 rose to $2.41 billion from $2.22 billion a year earlier, driven by both Health, Wealth & Career and Risk & Broking.
Profitability improved. Net income attributable to WTW increased to $297 million from $235 million, and diluted earnings per share climbed to $3.10 from $2.33. The effective tax rate fell to 18.6% from 21.5%, helped by a discrete UK tax benefit.
Cash flow and balance sheet shifted due to acquisitions and refinancing. Operating cash flow was a modest outflow of $10 million, while total cash, cash equivalents and restricted cash fell to $5.41 billion after $840 million used in investing, including the $1.05 billion Newfront Insurance Holdings acquisition. Long‑term debt rose to $6.30 billion, including a $550 million draw on a new delayed draw term loan used to repay $550 million of 4.400% senior notes due 2026.
Willis Towers Watson reported steady Q3 performance and a sharp year-over-year turnaround. Revenue was $2,288 million versus $2,289 million a year ago. Net income attributable to WTW was $304 million, compared with a loss of $(1,675) million in Q3 2024, reflecting the absence of last year’s large impairment and improved other income. Diluted EPS was $3.11 versus $(16.44) a year earlier.
For the first nine months, revenue was $6,772 million versus $6,895 million, and net income attributable to WTW was $870 million versus a loss of $(1,344) million. Operating cash flow reached $1,004 million. The company repurchased $1,300 million of shares year‑to‑date and reduced long‑term debt to $4,763 million from $5,309 million at year‑end. Segment mix shifted with Risk & Broking Q3 revenue up to $1,010 million while Health, Wealth & Career declined to $1,277 million. As of October 28, 2025, outstanding ordinary shares were 95,748,613.
Willis Towers Watson (WTW) delivered a markedly more profitable Q2 2025 despite flat top-line growth. Revenue was $2.26 bn, virtually unchanged YoY, but disciplined cost control after the 2024 Transformation program lifted operating income 73% to $368 m and expanded the operating margin to 16.3% (vs 9.4%). Net income attributable to WTW more than doubled to $331 m, driving diluted EPS to $3.32 from $1.36. For the first six months, EPS rose 76% to $5.64 while revenue slipped 2.6% to $4.48 bn.
- Segment trends: Health, Wealth & Career revenue fell 6% but maintained a 23.9% operating margin; Risk & Broking rose 7.5% with margin up to 21.2%.
- Balance sheet: Cash increased to $1.96 bn; long-term debt cut 10% to $4.76 bn, lowering leverage. AOCL improved by $452 m.
- Capital returns: Company repurchased $700 m of shares in H1, shrinking share count to 97.9 m; dividends paid totaled $179 m.
- Cash flow: Operating cash flow fell 24% to $326 m; a $836 m divestiture boosted investing inflows, while heavy buybacks drove a $800 m financing outflow.
- Guidance & outlook: Management highlights continued margin expansion post-transformation but notes macro, FX and regulatory risks within the 10-Q.